Home 
Today's Top Picks 
Top Performers 
Watchlist 
My Robo Portfolios 
ETF Zone 
Help & Tutorial 
Cancel anytime
- Chart
- Upturn Summary
- Highlights
- Valuation
Upturn AI SWOT - About
Spectral AI Inc (MDAIW)
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)
Stock price based on last close (see disclosures)
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
09/17/2025: MDAIW (2-star) is currently NOT-A-BUY. Pass it for now.
Upturn Star Rating
Below Average Performance
These Stocks/ETFs, based on Upturn Advisory, often underperform the market, warranting careful consideration before investing.
Analysis of Past Performance
Type Stock | Historic Profit 113.84% | Avg. Invested days 23 | Today’s Advisory PASS |
Upturn Star Rating | Upturn Advisory Performance  2.0 | Stock Returns Performance  5.0 |
| Profits based on simulation | Last Close 09/17/2025 |
Key Highlights
Company Size ETF | Market Capitalization 0 USD | Price to earnings Ratio - | 1Y Target Price - |
Price to earnings Ratio - | 1Y Target Price - | ||
Volume (30-day avg) - | Beta 0.7 | 52 Weeks Range 0.09 - 0.90 | Updated Date 06/28/2025 |
52 Weeks Range 0.09 - 0.90 | Updated Date 06/28/2025 | ||
Dividends yield (FY) - | Basic EPS (TTM) - |
Earnings Date
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin -30.75% | Operating Margin (TTM) -13.36% |
Management Effectiveness
Return on Assets (TTM) -18.42% | Return on Equity (TTM) -2308.32% |
Valuation
Trailing PE - | Forward PE - | Enterprise Value - | Price to Sales(TTM) - |
Enterprise Value - | Price to Sales(TTM) - | ||
Enterprise Value to Revenue - | Enterprise Value to EBITDA - | Shares Outstanding - | Shares Floating 17924135 |
Shares Outstanding - | Shares Floating 17924135 | ||
Percent Insiders - | Percent Institutions - |
Upturn AI SWOT
Spectral AI Inc
Company Overview
History and Background
Spectral AI Inc. was founded to develop and commercialize its proprietary DeepViewu00ae technology for assessing burn wounds. The company has focused on clinical validation and regulatory approvals.
Core Business Areas
- DeepViewu00ae System: Spectral AI's primary business is centered around its DeepViewu00ae System, a non-invasive imaging device that assesses burn wound severity and guides treatment decisions.
Leadership and Structure
Key leaders include the CEO, CFO, and heads of R&D and commercial operations. The organizational structure is typical of a small, publicly traded medical device company.
Top Products and Market Share
Key Offerings
- DeepViewu00ae System: The DeepViewu00ae System is the company's sole marketed product. Market share data is not readily available due to the niche market and limited commercialization. Competitors are companies with alternative burn assessment technologies, including clinical judgment and visual assessment.
Market Dynamics
Industry Overview
The industry involves burn care and wound management, including diagnostic tools and treatments. It's characterized by evolving technologies and a focus on improving patient outcomes.
Positioning
Spectral AI aims to establish DeepViewu00ae as the standard of care for burn wound assessment, offering objective and data-driven insights to guide treatment. Competitive advantage lies in non-invasive, predictive capabilities.
Total Addressable Market (TAM)
Estimated TAM for burn wound diagnostics is significant, driven by the incidence of burn injuries globally. Spectral AI is positioned to capture a segment of this market with its advanced technology.
Upturn SWOT Analysis
Strengths
- Proprietary DeepViewu00ae technology
- Non-invasive burn wound assessment
- Potential for improved clinical outcomes
- Strong intellectual property protection
Weaknesses
- Limited commercialization to date
- Reliance on single product
- Need for widespread clinical adoption
- Limited financial resources
Opportunities
- Expanding clinical applications beyond burns
- Partnerships with hospitals and burn centers
- International market expansion
- Developing AI-powered treatment recommendations
Threats
- Competition from existing burn assessment methods
- Slow adoption by clinicians
- Regulatory hurdles
- Reimbursement challenges
Competitors and Market Share
Key Competitors
- Smith & Nephew (SNN)
- Mu00f6lnlycke Health Care
Competitive Landscape
Spectral AI competes with established wound care companies and traditional clinical assessments. Its advantage lies in objective, non-invasive assessment, but needs to overcome adoption hurdles.
Growth Trajectory and Initiatives
Historical Growth: Historical growth is limited due to the early stage of commercialization.
Future Projections: Future growth depends on the successful adoption of DeepViewu00ae and expansion into new markets. Analyst estimates are not consistently available.
Recent Initiatives: Recent initiatives focus on securing regulatory approvals and building commercial partnerships.
Summary
Spectral AI Inc. is an early-stage medical device company with promising technology for burn wound assessment. Its DeepView system offers potential for improved clinical outcomes, but faces challenges in commercialization and adoption. The company needs to secure partnerships and demonstrate cost-effectiveness to achieve significant market penetration. Limited financial resources and competition from established players pose key risks to watch out for.
Peer Comparison
Sources and Disclaimers
Data Sources:
- Spectral AI Inc. website
- Company SEC filings
- Industry reports
Disclaimers:
This analysis is based on publicly available information and is for informational purposes only. It does not constitute financial advice.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About Spectral AI Inc
Exchange NASDAQ | Headquaters Dallas, TX, United States | ||
IPO Launch date 2021-04-05 | Co-Founder, Chief Innovation Strategist & Senior Advisor to the CEO Mr. Wensheng Fan | ||
Sector Healthcare | Industry Medical Devices | Full time employees 78 | Website https://www.spectral-ai.com |
Full time employees 78 | Website https://www.spectral-ai.com | ||
Spectral AI, Inc., an artificial intelligence (AI) company, focuses on predictive medical diagnostics in the United States. Its product, DeepView System, uses proprietary AI algorithms to distinguish between fully damaged, partially damaged, and healthy human tissue characteristics invisible to the naked eye, at the initial time point of wound presentation; and delivers a binary prediction on the wounds capacity to heal or not heal by a specified time point in the future to assist the physician in making a more accurate, timely and informed decision regarding the treatment of the patient's wounds. The company's system also includes MSI imaging technology, a proprietary multi-spectral optics and sensors, capturing injured tissue images; and AI-Burn software. Spectral AI, Inc. is headquartered in Dallas, Texas.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.